{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T10:10:25Z","timestamp":1778753425912,"version":"3.51.4"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2024,7,2]],"date-time":"2024-07-02T00:00:00Z","timestamp":1719878400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,7,2]],"date-time":"2024-07-02T00:00:00Z","timestamp":1719878400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005690","name":"Universit\u00e4t des Saarlandes","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005690","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Toxicol"],"published-print":{"date-parts":[[2024,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Many fatal intoxications have been reported in connection with the consumption of newer, highly potent synthetic cannabinoids. Yet, a possible postmortem redistribution (PMR) might complicate reliable interpretation of analytical results. Thus, it is necessary to investigate the PMR-potential of new synthetic cannabinoids. The pig model has already proven to be suitable for this purpose. Hence, the aim of this study was to study the PMR of the synthetic cannabinoid 5F-MDMB-P7AICA and its main metabolite 5F-MDMB-P7AICA-dimethylbutanoic acid (DBA). 5F-MDMB-P7AICA (200\u00a0\u00b5g\/kg body weight) was administered by inhalation to anesthetized and ventilated pigs. At the end of the experiment, the animals were euthanized and stored at room temperature for 3\u00a0days. Tissue and body fluid samples were taken daily. Specimens were analyzed after solid phase extraction using a standard addition method and LC\u2013MS\/MS, blood was quantified after protein precipitation using a validated method. In perimortem samples, 5F-MDMB-P7AICA was found mainly in adipose tissue, bile fluid, and duodenum contents. Small amounts of 5F-MDMB-P7AICA were found in blood, muscle, brain, liver, and lung. High concentrations of DBA were found primarily in bile fluid, duodenum contents, urine, and kidney\/perirenal fat tissue. In the remaining tissues, rather low amounts could be found. In comparison to older synthetic cannabinoids, PMR of 5F-MDMB-P7AICA was less pronounced. Concentrations in blood also appear to remain relatively stable at a low level postmortem. Muscle, kidney, fat, and duodenum content are suitable alternative matrices for the detection of 5F-MDMB-P7AICA and DBA, if blood specimens are not available. In conclusion, concentrations of 5F-MDMB-P7AICA and its main metabolite DBA are not relevantly affected by PMR.<\/jats:p>","DOI":"10.1007\/s00204-024-03815-1","type":"journal-article","created":{"date-parts":[[2024,7,2]],"date-time":"2024-07-02T20:41:46Z","timestamp":1719952906000},"page":"3289-3298","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Does a postmortem redistribution affect the concentrations of the 7 azaindole-derived synthetic cannabinoid 5F-MDMB-P7AICA in tissues and body fluids following pulmonary administration to pigs?"],"prefix":"10.1007","volume":"98","author":[{"given":"Adrian A.","family":"Doerr","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frederike","family":"Nordmeier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadja","family":"Walle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias W.","family":"Laschke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael D.","family":"Menger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus R.","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter H.","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5589-9370","authenticated-orcid":false,"given":"Nadine","family":"Schaefer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,7,2]]},"reference":[{"issue":"11","key":"3815_CR1","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1080\/15563650.2019.1580371","volume":"57","author":"P Adamowicz","year":"2019","unstructured":"Adamowicz P, Meissner E, Ma\u015blanka M (2019) Fatal intoxication with new synthetic cannabinoids AMB-FUBINACA and EMB-FUBINACA. Clin Toxicol 57(11):1103\u20131108. https:\/\/doi.org\/10.1080\/15563650.2019.1580371","journal-title":"Clin Toxicol"},{"key":"3815_CR2","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s40001-023-01443-6","volume":"29","author":"A Alzu\u2019bi","year":"2024","unstructured":"Alzu\u2019bi A, Almahasneh F, Khasawneh R et al (2024) The synthetic cannabinoids menace: a review of health risks and toxicity. Eur J Med Res 29:49. https:\/\/doi.org\/10.1186\/s40001-023-01443-6","journal-title":"Eur J Med Res"},{"issue":"1","key":"3815_CR3","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1093\/bja\/65.1.79","volume":"65","author":"YS Bakhle","year":"1990","unstructured":"Bakhle YS (1990) Pharmacokinetic and metabolic properties of lung. Br J Anaesth 65(1):79\u201393. https:\/\/doi.org\/10.1093\/bja\/65.1.79","journal-title":"Br J Anaesth"},{"key":"3815_CR4","doi-asserted-by":"publisher","first-page":"e10","DOI":"10.1016\/j.forsciint.2017.01.020","volume":"273","author":"B Barcelo","year":"2017","unstructured":"Barcelo B, Pichini S, Lopez-Corominas V et al (2017) Acute intoxication caused by synthetic cannabinoids 5F-ADB and MMB-2201: a case series. Forensic Sci Int 273:e10\u2013e14. https:\/\/doi.org\/10.1016\/j.forsciint.2017.01.020","journal-title":"Forensic Sci Int"},{"key":"3815_CR5","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1146\/annurev.pa.25.040185.000525","volume":"25","author":"JR Bend","year":"1985","unstructured":"Bend JR, Serabjit-Singh CJ, Philpot RM (1985) The pulmonary uptake, accumulation, and metabolism of xenobiotics. Annu Rev Pharmacol Toxicol 25:97\u2013125. https:\/\/doi.org\/10.1146\/annurev.pa.25.040185.000525","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"3815_CR6","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1042\/cs20231156","volume":"138","author":"Y Bo","year":"2024","unstructured":"Bo Y, Zhao X, Li L (2024) Cardiotoxic effects of common and emerging drugs: role of cannabinoid receptors. Clin Sci 138:413\u2013434. https:\/\/doi.org\/10.1042\/cs20231156","journal-title":"Clin Sci"},{"issue":"1","key":"3815_CR7","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1093\/bja\/aeg117","volume":"91","author":"F Boer","year":"2003","unstructured":"Boer F (2003) Drug handling by the lungs. Br J Anaesth 91(1):50\u201360. https:\/\/doi.org\/10.1093\/bja\/aeg117","journal-title":"Br J Anaesth"},{"key":"3815_CR18","unstructured":"De Morais J, Brandt S, Jorge R et al. (2020) EMCDDA technical report on the new psychoactive substance methyl 2-{[1-(4-fluorobutyl)-1H-indole-3-carbonyl]amino}-3,3-dimethylbutanoate (4F-MDMB-BICA). European Monitoring Centre for Drugs and Drug Addiction"},{"key":"3815_CR8","doi-asserted-by":"publisher","first-page":"990","DOI":"10.3390\/brainsci13070990","volume":"13","author":"MC De Oliveira","year":"2023","unstructured":"De Oliveira MC, Vides MC, Lassi DLS et al (2023) Toxicity of synthetic cannabinoids in K2\/Spice: a systematic review. Brain Sci 13:990. https:\/\/doi.org\/10.3390\/brainsci13070990","journal-title":"Brain Sci"},{"key":"3815_CR9","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1093\/jat\/bkaa122","volume":"45","author":"AA Doerr","year":"2020","unstructured":"Doerr AA, Nordmeier F, Walle N et al (2020) Can a recently developed pig model be used for in vivo metabolism studies of 7-azaindole derived synthetic cannabinoids? A study using 5F-MDMB-P7AICA. J Anal Toxicol 45:593\u2013604. https:\/\/doi.org\/10.1093\/jat\/bkaa122","journal-title":"J Anal Toxicol"},{"key":"3815_CR10","volume-title":"European Drug Report 2023: trends and developments","author":"EMCDDA","year":"2023","unstructured":"EMCDDA (2023) European Drug Report 2023: trends and developments. Publications Office of the European Union, Luxembourg"},{"key":"3815_CR11","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1007\/s00414-018-1911-8","volume":"132","author":"F Gaunitz","year":"2018","unstructured":"Gaunitz F, Lehmann S, Thomas A et al (2018) Post-mortem distribution of the synthetic cannabinoid MDMB-CHMICA and its metabolites in a case of combined drug intoxication. Int J Legal Med 132:1645\u20131657. https:\/\/doi.org\/10.1007\/s00414-018-1911-8","journal-title":"Int J Legal Med"},{"key":"3815_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2020.00464","author":"A Giorgetti","year":"2020","unstructured":"Giorgetti A, Busard\u00f2 FP, Tittarelli R, Auw\u00e4rter V, Giorgetti R (2020) Post-mortem toxicology: a systematic review of death cases involving synthetic cannabinoid receptor agonists. Front Psychiatry. https:\/\/doi.org\/10.3389\/fpsyt.2020.00464","journal-title":"Front Psychiatry"},{"issue":"1","key":"3815_CR13","first-page":"14","volume":"85","author":"GTFCh,","year":"2018","unstructured":"GTFCh, (2018) Empfehlungen zur Asservierung von Obduktionsmaterial f\u00fcr forensisch-toxikologische Untersuchungen und spezielle Aspekte der Postmortem-Analytik. Toxichem Krimtech 85(1):14\u201328","journal-title":"Toxichem Krimtech"},{"issue":"1\u20133","key":"3815_CR14","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.forsciint.2012.01.016","volume":"219","author":"E Han","year":"2012","unstructured":"Han E, Kim E, Hong H et al (2012) Evaluation of postmortem redistribution phenomena for commonly encountered drugs. Forensic Sci Int 219(1\u20133):265\u2013271. https:\/\/doi.org\/10.1016\/j.forsciint.2012.01.016","journal-title":"Forensic Sci Int"},{"key":"3815_CR15","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1051\/ata\/2009023","volume":"20","author":"SM Jickells","year":"2008","unstructured":"Jickells SM, Negrusz A (2008) Clarke\u2019s analytical forensic toxicology. Ann Toxicol Anal 20:233\u2013234. https:\/\/doi.org\/10.1051\/ata\/2009023","journal-title":"Ann Toxicol Anal"},{"issue":"1","key":"3815_CR16","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1093\/jat\/bkaa054","volume":"45","author":"AJ Krotulski","year":"2020","unstructured":"Krotulski AJ, Bishop-Freeman SC, Mohr ALA, Logan BK (2020) Evaluation of synthetic cannabinoid metabolites in human blood in the absence of parent compounds: a stability assessment. J Anal Toxicol 45(1):60\u201368. https:\/\/doi.org\/10.1093\/jat\/bkaa054","journal-title":"J Anal Toxicol"},{"issue":"1","key":"3815_CR17","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s12024-013-9503-x","volume":"10","author":"IM McIntyre","year":"2014","unstructured":"McIntyre IM (2014) Liver and peripheral blood concentration ratio (L\/P) as a marker of postmortem drug redistribution: a literature review. Forensic Sci Med Pathol 10(1):91\u201396. https:\/\/doi.org\/10.1007\/s12024-013-9503-x","journal-title":"Forensic Sci Med Pathol"},{"key":"3815_CR19","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1520\/JFS14405J","volume":"44","author":"F Moriya","year":"1999","unstructured":"Moriya F, Hashimoto Y (1999) Redistribution of basic drugs into cardiac blood from surrounding tissues during early-stages postmortem. J for Sci 44:10\u201316. https:\/\/doi.org\/10.1520\/JFS14405J","journal-title":"J for Sci"},{"issue":"2","key":"3815_CR20","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.forsciint.2006.05.021","volume":"165","author":"FT Peters","year":"2007","unstructured":"Peters FT, Drummer OH, Musshoff F (2007) Validation of new methods. Forensic Sci Int 165(2):216\u2013224. https:\/\/doi.org\/10.1016\/j.forsciint.2006.05.021","journal-title":"Forensic Sci Int"},{"key":"3815_CR21","doi-asserted-by":"publisher","DOI":"10.1002\/bmc.4884","volume":"34","author":"BC Presley","year":"2020","unstructured":"Presley BC, Castaneto MS, Logan BK et al (2020) Assessment of synthetic cannabinoid FUB-AMB and its ester hydrolysis metabolite in human liver microsomes and human blood samples using UHPLC\u2013MS\/MS. Biomed Chromatogr 34:e4884. https:\/\/doi.org\/10.1002\/bmc.4884","journal-title":"Biomed Chromatogr"},{"issue":"2","key":"3815_CR22","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1002\/dta.2493","volume":"11","author":"LHJ Richter","year":"2019","unstructured":"Richter LHJ, Maurer HH, Meyer MR (2019) Metabolic fate of the new synthetic cannabinoid 7\u2032N-5F-ADB in rat, human, and pooled human S9 studied by means of hyphenated high-resolution mass spectrometry. Drug Test Anal 11(2):305\u2013317. https:\/\/doi.org\/10.1002\/dta.2493","journal-title":"Drug Test Anal"},{"issue":"13","key":"3815_CR23","doi-asserted-by":"publisher","first-page":"3775","DOI":"10.1007\/s00216-015-8605-6","volume":"407","author":"N Schaefer","year":"2015","unstructured":"Schaefer N, Kettner M, Laschke MW et al (2015) Simultaneous LC-MS\/MS determination of JWH-210, RCS-4, \u22069-tetrahydrocannabinol, and their main metabolites in pig and human serum, whole blood, and urine for comparing pharmacokinetic data. Anal Bioanal Chem 407(13):3775\u20133786. https:\/\/doi.org\/10.1007\/s00216-015-8605-6","journal-title":"Anal Bioanal Chem"},{"issue":"5","key":"3815_CR24","doi-asserted-by":"publisher","first-page":"713","DOI":"10.2174\/1570159X15666161111114214","volume":"15","author":"N Schaefer","year":"2017","unstructured":"Schaefer N, Kettner M, Laschke MW et al (2017) Distribution of synthetic cannabinoids JWH-210, RCS-4 and delta 9-tetrahydrocannabinol after intravenous administration to pigs. Curr Neuropharmacol 15(5):713\u2013723. https:\/\/doi.org\/10.2174\/1570159X15666161111114214","journal-title":"Curr Neuropharmacol"},{"issue":"8","key":"3815_CR25","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.1007\/s00204-019-02493-8","volume":"93","author":"N Schaefer","year":"2019","unstructured":"Schaefer N, Kr\u00f6ll A-K, K\u00f6rbel C et al (2019) Distribution of the (synthetic) cannabinoids JWH-210, RCS-4, as well as \u22069-tetrahydrocannabinol following pulmonary administration to pigs. Arch Toxicol 93(8):2211\u20132218. https:\/\/doi.org\/10.1007\/s00204-019-02493-8","journal-title":"Arch Toxicol"},{"issue":"5","key":"3815_CR26","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1007\/s00204-020-02707-4","volume":"94","author":"N Schaefer","year":"2020","unstructured":"Schaefer N, Kr\u00f6ll A-K, K\u00f6rbel C et al (2020a) Time- and temperature-dependent postmortem concentration changes of the (synthetic) cannabinoids JWH-210, RCS-4, as well as \u22069-tetrahydrocannabinol following pulmonary administration to pigs. Arch Toxicol 94(5):1585\u20131599. https:\/\/doi.org\/10.1007\/s00204-020-02707-4","journal-title":"Arch Toxicol"},{"issue":"10","key":"3815_CR27","doi-asserted-by":"publisher","first-page":"3421","DOI":"10.1007\/s00204-020-02843-x","volume":"94","author":"N Schaefer","year":"2020","unstructured":"Schaefer N, Nordmeier F, Kr\u00f6ll AK et al (2020b) Is adipose tissue suitable for detection of (synthetic) cannabinoids? A comparative study analyzing antemortem and postmortem specimens following pulmonary administration of JWH-210, RCS-4, as well as \u22069-tetrahydrocannabinol to pigs. Arch Toxicol 94(10):3421\u20133431. https:\/\/doi.org\/10.1007\/s00204-020-02843-x","journal-title":"Arch Toxicol"},{"key":"3815_CR28","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1007\/s12024-010-9150-4","volume":"6","author":"G Skopp","year":"2010","unstructured":"Skopp G (2010) Postmortem toxicology. Forensic Sci Med Pathol 6:314\u2013325. https:\/\/doi.org\/10.1007\/s12024-010-9150-4","journal-title":"Forensic Sci Med Pathol"},{"key":"3815_CR29","doi-asserted-by":"publisher","DOI":"10.1002\/9780470061589.fsa417.pub2","author":"GA Skopp","year":"2012","unstructured":"Skopp GA (2012) Postmortem toxicology. Artifacts Wiley Encycl Forensic Sci. https:\/\/doi.org\/10.1002\/9780470061589.fsa417.pub2","journal-title":"Artifacts Wiley Encycl Forensic Sci"},{"key":"3815_CR30","unstructured":"SOFT\/AAFS (2006) Forensic toxicology laboratory guidelines. http:\/\/www.the-ltg.org\/data\/uploads\/guidelines\/soft-guidelines_2006.pdf Accessed May 2024"},{"key":"3815_CR31","doi-asserted-by":"publisher","DOI":"10.1093\/jat\/bkab022","author":"N Walle","year":"2021","unstructured":"Walle N, Doerr AA, Laschke MW et al (2021) Systematic studies on temperature-dependent in vitro stability during storage and smoking of the synthetic cannabinoid 5F-MDMB-P7AICA. J Anal Toxicol. https:\/\/doi.org\/10.1093\/jat\/bkab022","journal-title":"J Anal Toxicol"},{"issue":"3","key":"3815_CR32","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1002\/dta.3401","volume":"15","author":"N Walle","year":"2023","unstructured":"Walle N, Doerr AA, Schmidt PH, Schaefer N (2023) \u2018Flying high?\u2019-Jump from a height in a \u2018Spice\u2019 high? A case report on the synthetic cannabinoid 5F-MDMB-P7AICA. Drug Test Anal 15(3):368\u2013373. https:\/\/doi.org\/10.1002\/dta.3401","journal-title":"Drug Test Anal"},{"key":"3815_CR33","doi-asserted-by":"crossref","unstructured":"Walle N, Doerr AA, Peters B, et al. (2024) Are the postmortem concentration changes of the synthetic cannabinoid cumyl-5F-P7AICA and its N-pentanoic acid metabolite dependent on the environmental conditions? A systematic study following pulmonary administration to pigs. Toxicol Lett (submitted)","DOI":"10.1016\/j.toxlet.2024.10.006"},{"key":"3815_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpba.2024.115988","volume":"241","author":"Y Xu","year":"2024","unstructured":"Xu Y, Li X, Xu P et al (2024) Comparative pharmacokinetic and intracerebral distribution of MDMB-4F-BICA in mice following inhalation (\u2018vapor\u2019) and subcutaneous injection. J Pharm Biomed Anal 241:115988. https:\/\/doi.org\/10.1016\/j.jpba.2024.115988","journal-title":"J Pharm Biomed Anal"},{"key":"3815_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.forsciint.2019.06.024","volume":"302","author":"O Yeter","year":"2019","unstructured":"Yeter O, Erol Ozturk Y (2019) Detection and quantification of 5F-ADB and its methyl ester hydrolysis metabolite in fatal intoxication cases by liquid chromatography-high resolution mass spectrometry. Forensic Sci Int 302:109866. https:\/\/doi.org\/10.1016\/j.forsciint.2019.06.024","journal-title":"Forensic Sci Int"},{"key":"3815_CR36","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1007\/s00414-015-1257-4","volume":"129","author":"K Zaitsu","year":"2015","unstructured":"Zaitsu K, Nakayama H, Yamanaka M et al (2015) High-resolution mass spectrometric determination of the synthetic cannabinoids MAM-2201, AM-2201, AM-2232, and their metabolites in postmortem plasma and urine by LC\/Q-TOFMS. Int J Legal Med 129:1233\u20131245. https:\/\/doi.org\/10.1007\/s00414-015-1257-4","journal-title":"Int J Legal Med"}],"container-title":["Archives of Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-024-03815-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00204-024-03815-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-024-03815-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,23]],"date-time":"2024-11-23T09:25:16Z","timestamp":1732353916000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00204-024-03815-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,2]]},"references-count":36,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["3815"],"URL":"https:\/\/doi.org\/10.1007\/s00204-024-03815-1","relation":{},"ISSN":["0340-5761","1432-0738"],"issn-type":[{"value":"0340-5761","type":"print"},{"value":"1432-0738","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,2]]},"assertion":[{"value":"10 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"There are no financial or other relations that could lead to a conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All experiments were performed in accordance with the German legislation on protection of animals and the National Institutes of Health Guide for the Care and Use of Laboratory Animals (permission number: 32\/2018).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}